Vivimed Labs Ltd.
•₹ 6.244.87%
2026-08-21
PROS
- Company is almost debt free
- Working capital cycle has improved - days down from -166 to -253
- Company generates healthy free cash flow
CONS
- Net worth is negative - accumulated losses have eroded equity
- Company is loss-making at the operating / net level
- Company has a low return on equity of -66.8% over last 3 years
- Company has a low return on capital employed of -25.5%
- Operating cash flow has been negative in recent years
- Interest coverage is weak at -9.7x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | VIVIMEDLAB | 5.67 | 0.00 | 47.01 | 0.00 | -147.12 | -2527.20 | 12.00 | -53.14 | -9.07 | -1168.99 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37 | 35 | 34 | 41 | 39 | 29 | 25 | 37 | 26 | 21 | 21 | 16 | 12 | |
| 201 | 36 | 40 | 40 | 67 | 40 | 25 | 35 | 28 | 22 | 22 | 27 | 165 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 1 | 0 | 2 | 0 | 8 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 6 |
| Interest | 9 | 11 | 12 | 13 | -33 | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 1 |
| Depreciation | 96 | 5 | 5 | 5 | 6 | 4 | 4 | 7 | 6 | 5 | 5 | 5 | 12 |
| -268 | -16 | -20 | -17 | 7 | -15 | -5 | -6 | -5 | -5 | -7 | -17 | -147 | |
| Tax % | 0.77% | -0.00% | -0.00% | 3.31% | 20.90% | -0.00% | -0.00% | -0.00% | -2.00% | -0.00% | -0.00% | -0.00% | -0.09% |
| Net Profit | 0 | 0 | 0 | 0 | 5 | -15 | -5 | -6 | -6 | -5 | -7 | -17 | -147 |
| -32 | -2 | -2 | -2 | 1 | -2 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Mar 2023
- 37
- 201
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 9
- Depreciation
- 96
- -268
- Tax %
- 0.77%
- Net Profit
- 0
- -32
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2023
- 35
- 36
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 11
- Depreciation
- 5
- -16
- Tax %
- -0.00%
- Net Profit
- 0
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 34
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 12
- Depreciation
- 5
- -20
- Tax %
- -0.00%
- Net Profit
- 0
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 41
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 13
- Depreciation
- 5
- -17
- Tax %
- 3.31%
- Net Profit
- 0
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 39
- 67
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- -33
- Depreciation
- 6
- 7
- Tax %
- 20.90%
- Net Profit
- 5
- 1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 29
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 4
- -15
- Tax %
- -0.00%
- Net Profit
- -15
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 25
- 25
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 4
- -5
- Tax %
- -0.00%
- Net Profit
- -5
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 37
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 0
- Depreciation
- 7
- -6
- Tax %
- -0.00%
- Net Profit
- -6
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 26
- 28
- Operating Profit
- —
- OPM %
- —
- Other Income
- 4
- Interest
- 2
- Depreciation
- 6
- -5
- Tax %
- -2.00%
- Net Profit
- -6
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 21
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- -5
- Tax %
- -0.00%
- Net Profit
- -5
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 21
- 22
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 5
- -7
- Tax %
- -0.00%
- Net Profit
- -7
- -1
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 16
- 27
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- -17
- Tax %
- -0.00%
- Net Profit
- -17
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 12
- 165
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 1
- Depreciation
- 12
- -147
- Tax %
- -0.09%
- Net Profit
- -147
- -2
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 17
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,346 | 1,462 | 1,186 | 1,315 | 1,059 | 861 | 237 | 187 | 149 | 116 | 70 | |
| 1,123 | 1,057 | 985 | 1,146 | 1,052 | 830 | 245 | 374 | 182 | 129 | 235 | |
| Operating Profit | 247 | 413 | 224 | 203 | 18 | 42 | -7 | -186 | -23 | -9 | — |
| OPM % | 18 | 28 | 19 | 15 | 2 | 5 | -3 | -99 | -15 | -7 | — |
| Other Income | 24 | 8 | 24 | 34 | 12 | 10 | 1 | 1 | 10 | 4 | 6 |
| Interest | 85 | 68 | 82 | 70 | 61 | 56 | 40 | 36 | 3 | 3 | 4 |
| Depreciation | 61 | 58 | 56 | 67 | 67 | 55 | 18 | 108 | 20 | 20 | 26 |
| 100 | 286 | 86 | 66 | -109 | -70 | -65 | -331 | -46 | -32 | -176 | |
| Tax % | 16 | 25 | 11 | 13 | 0 | -3 | -4 | 1 | 1 | -0 | -0 |
| Net Profit | 84 | 214 | 76 | 57 | -109 | -72 | -68 | -329 | -45 | -32 | -176 |
| EPS | 0 | 0 | 0 | 0 | -13 | -8 | -8 | -38 | -5 | -4 | — |
| Dividend Payout % | 0 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 26 | 9 | 7 | -13 | -9 | -8 | -40 | -5 | -4 | — |
| Minority Interest | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 26 | 9 | 7 | -13 | -9 | -8 | -40 | -5 | -4 | — |
Mar 2016
- 1,346
- 1,123
- Operating Profit
- 247
- OPM %
- 18
- Other Income
- 24
- Interest
- 85
- Depreciation
- 61
- 100
- Tax %
- 16
- Net Profit
- 84
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2017
- 1,462
- 1,057
- Operating Profit
- 413
- OPM %
- 28
- Other Income
- 8
- Interest
- 68
- Depreciation
- 58
- 286
- Tax %
- 25
- Net Profit
- 214
- EPS
- 0
- Dividend Payout %
- 2
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 26
Mar 2018
- 1,186
- 985
- Operating Profit
- 224
- OPM %
- 19
- Other Income
- 24
- Interest
- 82
- Depreciation
- 56
- 86
- Tax %
- 11
- Net Profit
- 76
- EPS
- 0
- Dividend Payout %
- 4
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 2
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2019
- 1,315
- 1,146
- Operating Profit
- 203
- OPM %
- 15
- Other Income
- 34
- Interest
- 70
- Depreciation
- 67
- 66
- Tax %
- 13
- Net Profit
- 57
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2020
- 1,059
- 1,052
- Operating Profit
- 18
- OPM %
- 2
- Other Income
- 12
- Interest
- 61
- Depreciation
- 67
- -109
- Tax %
- 0
- Net Profit
- -109
- EPS
- -13
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -13
Mar 2021
- 861
- 830
- Operating Profit
- 42
- OPM %
- 5
- Other Income
- 10
- Interest
- 56
- Depreciation
- 55
- -70
- Tax %
- -3
- Net Profit
- -72
- EPS
- -8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -9
Mar 2022
- 237
- 245
- Operating Profit
- -7
- OPM %
- -3
- Other Income
- 1
- Interest
- 40
- Depreciation
- 18
- -65
- Tax %
- -4
- Net Profit
- -68
- EPS
- -8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -8
Mar 2023
- 187
- 374
- Operating Profit
- -186
- OPM %
- -99
- Other Income
- 1
- Interest
- 36
- Depreciation
- 108
- -331
- Tax %
- 1
- Net Profit
- -329
- EPS
- -38
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -40
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -40
Mar 2024
- 149
- 182
- Operating Profit
- -23
- OPM %
- -15
- Other Income
- 10
- Interest
- 3
- Depreciation
- 20
- -46
- Tax %
- 1
- Net Profit
- -45
- EPS
- -5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -5
Mar 2025
- 116
- 129
- Operating Profit
- -9
- OPM %
- -7
- Other Income
- 4
- Interest
- 3
- Depreciation
- 20
- -32
- Tax %
- -0
- Net Profit
- -32
- EPS
- -4
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -4
TTM
- 70
- 235
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 4
- Depreciation
- 26
- -176
- Tax %
- -0
- Net Profit
- -176
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- -22%
- 5 Years:
- -36%
- 3 Years:
- -21%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- -23%
- 5 Years:
- -22%
- 3 Years:
- -15%
- 1 Year:
- -39%
RETURN ON EQUITY
- 10 Years:
- -19%
- 5 Years:
- -47%
- 3 Years:
- -67%
- Last Year:
- 0%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| 16 | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | |
| 505 | 718 | 885 | 602 | 493 | 415 | 348 | 23 | -22 | -52 | |
| 408 | 381 | 385 | 332 | 419 | 195 | 218 | 225 | 313 | 313 | |
| Trade Payables | 167 | 179 | 202 | 294 | 227 | 34 | 42 | 55 | 44 | 39 |
| 948 | 761 | 897 | 1,077 | 1,042 | 628 | 642 | 676 | 599 | 604 | |
| Total Liabilities | 2,044 | 2,055 | 2,386 | 2,322 | 2,196 | 1,289 | 1,266 | 995 | 951 | 921 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 814 | 879 | 1,035 | 965 | 1,045 | 502 | 520 | 436 | 418 | 408 | |
| Capital Work in Progress | 94 | 76 | 65 | 122 | 89 | 60 | 40 | 21 | 21 | 17 |
| 3 | 3 | 3 | 3 | 86 | 199 | 199 | 199 | 168 | 168 | |
| 491 | 484 | 540 | 564 | 502 | 256 | 241 | 80 | 64 | 59 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 83 | 74 | |
| Cash & Bank | 31 | 55 | 99 | 95 | 50 | 6 | 7 | 4 | 2 | 1 |
| 611 | 558 | 643 | 574 | 423 | 267 | 259 | 256 | 195 | 194 | |
| Total Assets | 2,044 | 2,055 | 2,386 | 2,322 | 2,196 | 1,289 | 1,266 | 995 | 951 | 921 |
| Total Debt | 951 | 1,011 | 824 | 955 | 943 | 326 | 359 | 379 | 377 | 376 |
| Net Working Capital | 235 | 277 | 492 | 342 | 205 | 188 | 134 | -85 | -68 | -81 |
| Contingent Liabilities | 366 | 237 | 161 | 56 | 12 | 221 | 216 | 123 | 116 | 183 |
| Book Value per Share | 321.01 | 85.93 | 104.60 | 70.35 | 56.85 | 47.47 | 39.35 | 0.17 | -5.24 | -8.82 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 951 | 1,011 | 824 | 955 | 943 | 326 | 359 | 379 | 377 | 376 |
| Net Working Capital | 235 | 277 | 492 | 342 | 205 | 188 | 134 | -85 | -68 | -81 |
| Contingent Liabilities | 366 | 237 | 161 | 56 | 12 | 221 | 216 | 123 | 116 | 183 |
| Book Value per Share | 321.01 | 85.93 | 104.60 | 70.35 | 56.85 | 47.47 | 39.35 | 0.17 | -5.24 | -8.82 |
| Face Value | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2016
- 16
- 505
- 408
- Trade Payables
- 167
- 948
- Total Liabilities
- 2,044
- 814
- Capital Work in Progress
- 94
- 3
- 491
- 0
- Cash & Bank
- 31
- 611
- Total Assets
- 2,044
- Total Debt
- 951
- Net Working Capital
- 235
- Contingent Liabilities
- 366
- Book Value per Share
- 321.01
- Face Value
- 10.00
- Total Debt
- 951
- Net Working Capital
- 235
- Contingent Liabilities
- 366
- Book Value per Share
- 321.01
- Face Value
- 10.00
Mar 2017
- 16
- 718
- 381
- Trade Payables
- 179
- 761
- Total Liabilities
- 2,055
- 879
- Capital Work in Progress
- 76
- 3
- 484
- 0
- Cash & Bank
- 55
- 558
- Total Assets
- 2,055
- Total Debt
- 1,011
- Net Working Capital
- 277
- Contingent Liabilities
- 237
- Book Value per Share
- 85.93
- Face Value
- 2.00
- Total Debt
- 1,011
- Net Working Capital
- 277
- Contingent Liabilities
- 237
- Book Value per Share
- 85.93
- Face Value
- 2.00
Mar 2018
- 17
- 885
- 385
- Trade Payables
- 202
- 897
- Total Liabilities
- 2,386
- 1,035
- Capital Work in Progress
- 65
- 3
- 540
- 0
- Cash & Bank
- 99
- 643
- Total Assets
- 2,386
- Total Debt
- 824
- Net Working Capital
- 492
- Contingent Liabilities
- 161
- Book Value per Share
- 104.60
- Face Value
- 2.00
- Total Debt
- 824
- Net Working Capital
- 492
- Contingent Liabilities
- 161
- Book Value per Share
- 104.60
- Face Value
- 2.00
Mar 2019
- 17
- 602
- 332
- Trade Payables
- 294
- 1,077
- Total Liabilities
- 2,322
- 965
- Capital Work in Progress
- 122
- 3
- 564
- 0
- Cash & Bank
- 95
- 574
- Total Assets
- 2,322
- Total Debt
- 955
- Net Working Capital
- 342
- Contingent Liabilities
- 56
- Book Value per Share
- 70.35
- Face Value
- 2.00
- Total Debt
- 955
- Net Working Capital
- 342
- Contingent Liabilities
- 56
- Book Value per Share
- 70.35
- Face Value
- 2.00
Mar 2020
- 17
- 493
- 419
- Trade Payables
- 227
- 1,042
- Total Liabilities
- 2,196
- 1,045
- Capital Work in Progress
- 89
- 86
- 502
- 0
- Cash & Bank
- 50
- 423
- Total Assets
- 2,196
- Total Debt
- 943
- Net Working Capital
- 205
- Contingent Liabilities
- 12
- Book Value per Share
- 56.85
- Face Value
- 2.00
- Total Debt
- 943
- Net Working Capital
- 205
- Contingent Liabilities
- 12
- Book Value per Share
- 56.85
- Face Value
- 2.00
Mar 2021
- 17
- 415
- 195
- Trade Payables
- 34
- 628
- Total Liabilities
- 1,289
- 502
- Capital Work in Progress
- 60
- 199
- 256
- 0
- Cash & Bank
- 6
- 267
- Total Assets
- 1,289
- Total Debt
- 326
- Net Working Capital
- 188
- Contingent Liabilities
- 221
- Book Value per Share
- 47.47
- Face Value
- 2.00
- Total Debt
- 326
- Net Working Capital
- 188
- Contingent Liabilities
- 221
- Book Value per Share
- 47.47
- Face Value
- 2.00
Mar 2022
- 17
- 348
- 218
- Trade Payables
- 42
- 642
- Total Liabilities
- 1,266
- 520
- Capital Work in Progress
- 40
- 199
- 241
- 0
- Cash & Bank
- 7
- 259
- Total Assets
- 1,266
- Total Debt
- 359
- Net Working Capital
- 134
- Contingent Liabilities
- 216
- Book Value per Share
- 39.35
- Face Value
- 2.00
- Total Debt
- 359
- Net Working Capital
- 134
- Contingent Liabilities
- 216
- Book Value per Share
- 39.35
- Face Value
- 2.00
Mar 2023
- 17
- 23
- 225
- Trade Payables
- 55
- 676
- Total Liabilities
- 995
- 436
- Capital Work in Progress
- 21
- 199
- 80
- 0
- Cash & Bank
- 4
- 256
- Total Assets
- 995
- Total Debt
- 379
- Net Working Capital
- -85
- Contingent Liabilities
- 123
- Book Value per Share
- 0.17
- Face Value
- 2.00
- Total Debt
- 379
- Net Working Capital
- -85
- Contingent Liabilities
- 123
- Book Value per Share
- 0.17
- Face Value
- 2.00
Mar 2024
- 17
- -22
- 313
- Trade Payables
- 44
- 599
- Total Liabilities
- 951
- 418
- Capital Work in Progress
- 21
- 168
- 64
- 83
- Cash & Bank
- 2
- 195
- Total Assets
- 951
- Total Debt
- 377
- Net Working Capital
- -68
- Contingent Liabilities
- 116
- Book Value per Share
- -5.24
- Face Value
- 2.00
- Total Debt
- 377
- Net Working Capital
- -68
- Contingent Liabilities
- 116
- Book Value per Share
- -5.24
- Face Value
- 2.00
Mar 2025
- 17
- -52
- 313
- Trade Payables
- 39
- 604
- Total Liabilities
- 921
- 408
- Capital Work in Progress
- 17
- 168
- 59
- 74
- Cash & Bank
- 1
- 194
- Total Assets
- 921
- Total Debt
- 376
- Net Working Capital
- -81
- Contingent Liabilities
- 183
- Book Value per Share
- -8.82
- Face Value
- 2.00
- Total Debt
- 376
- Net Working Capital
- -81
- Contingent Liabilities
- 183
- Book Value per Share
- -8.82
- Face Value
- 2.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 154 | 58 | 21 | 422 | 80 | 567 | 28 | 35 | -24 | -2 | |
| Cash from Investing | -190 | -68 | -164 | -89 | -196 | 404 | -16 | -5 | 28 | -5 |
| Cash from Financing | 41 | 35 | 186 | -338 | 72 | -1,015 | -10 | -34 | -6 | 5 |
| 4 | 25 | 44 | -5 | -44 | -44 | 1 | -3 | -2 | -1 | |
| Free Cash Flow | 86 | 58 | -181 | 337 | -2 | 567 | 11 | 35 | -26 | -8 |
| OCF / Net Profit | 1.84 | 0.27 | 0.28 | 7.36 | -0.73 | -7.89 | -0.41 | -0.11 | 0.53 | 0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 299 | 780 | 733 | 949 | 586 | 580 |
| OCF / Net Profit | 1.84 | 0.27 | 0.28 | 7.36 | -0.73 | -7.89 | -0.41 | -0.11 | 0.53 | 0.05 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 299 | 780 | 733 | 949 | 586 | 580 |
Mar 2016
- 154
- Cash from Investing
- -190
- Cash from Financing
- 41
- 4
- Free Cash Flow
- 86
- OCF / Net Profit
- 1.84
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.84
- Cumulative 5-Year FCF
- 0
Mar 2017
- 58
- Cash from Investing
- -68
- Cash from Financing
- 35
- 25
- Free Cash Flow
- 58
- OCF / Net Profit
- 0.27
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.27
- Cumulative 5-Year FCF
- 0
Mar 2018
- 21
- Cash from Investing
- -164
- Cash from Financing
- 186
- 44
- Free Cash Flow
- -181
- OCF / Net Profit
- 0.28
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.28
- Cumulative 5-Year FCF
- 0
Mar 2019
- 422
- Cash from Investing
- -89
- Cash from Financing
- -338
- -5
- Free Cash Flow
- 337
- OCF / Net Profit
- 7.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 7.36
- Cumulative 5-Year FCF
- 0
Mar 2020
- 80
- Cash from Investing
- -196
- Cash from Financing
- 72
- -44
- Free Cash Flow
- -2
- OCF / Net Profit
- -0.73
- Cumulative 5-Year FCF
- 299
- OCF / Net Profit
- -0.73
- Cumulative 5-Year FCF
- 299
Mar 2021
- 567
- Cash from Investing
- 404
- Cash from Financing
- -1,015
- -44
- Free Cash Flow
- 567
- OCF / Net Profit
- -7.89
- Cumulative 5-Year FCF
- 780
- OCF / Net Profit
- -7.89
- Cumulative 5-Year FCF
- 780
Mar 2022
- 28
- Cash from Investing
- -16
- Cash from Financing
- -10
- 1
- Free Cash Flow
- 11
- OCF / Net Profit
- -0.41
- Cumulative 5-Year FCF
- 733
- OCF / Net Profit
- -0.41
- Cumulative 5-Year FCF
- 733
Mar 2023
- 35
- Cash from Investing
- -5
- Cash from Financing
- -34
- -3
- Free Cash Flow
- 35
- OCF / Net Profit
- -0.11
- Cumulative 5-Year FCF
- 949
- OCF / Net Profit
- -0.11
- Cumulative 5-Year FCF
- 949
Mar 2024
- -24
- Cash from Investing
- 28
- Cash from Financing
- -6
- -2
- Free Cash Flow
- -26
- OCF / Net Profit
- 0.53
- Cumulative 5-Year FCF
- 586
- OCF / Net Profit
- 0.53
- Cumulative 5-Year FCF
- 586
Mar 2025
- -2
- Cash from Investing
- -5
- Cash from Financing
- 5
- -1
- Free Cash Flow
- -8
- OCF / Net Profit
- 0.05
- Cumulative 5-Year FCF
- 580
- OCF / Net Profit
- 0.05
- Cumulative 5-Year FCF
- 580
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 51.64 | 26.41 | 9.44 | 6.95 | -13.16 | -8.67 | -8.16 | -39.62 | -5.48 | -3.85 |
| Book Value (₹) | 321.01 | 85.93 | 104.60 | 70.35 | 56.85 | 47.47 | 39.35 | 0.17 | -5.24 | -8.82 |
| Dividend per Share (₹) | 0.00 | 0.40 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 17.90 | 33.60 | 16.06 | 15.04 | -5.09 | -1.98 | -5.95 | -26.55 | -3.08 | -1.42 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 18.32% | 28.22% | 18.93% | 15.43% | 1.75% | 4.84% | -2.76% | -99.42% | -22.05% | -11.19% |
| Net Margin % | 6.22% | 14.64% | 6.42% | 4.36% | -10.31% | -8.34% | -28.51% | -175.59% | -30.49% | -27.49% |
| ROE % | 16.50% | 35.18% | 9.76% | 7.95% | -20.75% | -16.62% | -18.80% | -200.51% | 0.00% | 0.00% |
| ROCE % | 11.93% | 21.86% | 9.04% | 7.03% | -2.69% | -1.12% | -3.54% | -55.28% | -12.01% | -9.07% |
| 4.25% | 10.44% | 3.43% | 2.44% | -4.83% | -4.13% | -5.29% | -29.06% | -4.67% | -3.42% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 89 | 66 | 73 | 88 | 104 | 76 | 150 | 158 | 192 | 246 |
| Inventory Days | 125 | 122 | 158 | 153 | 184 | 160 | 382 | 313 | 176 | 193 |
| Payable Days | 104 | 118 | 145 | 175 | 206 | 134 | 91 | 65 | 254 | 255 |
| 110 | 70 | 86 | 66 | 82 | 102 | 441 | 405 | 115 | 185 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.63x | 1.45x | 0.69x | 1.05x | 1.18x | 0.83x | 1.10x | 266.22x | -8.67x | -5.14x |
| Interest Coverage (x) | 2.17x | 5.23x | 2.04x | 1.94x | -0.79x | -0.25x | -0.62x | -8.13x | -14.36x | -9.69x |
| 1.26x | 1.34x | 1.62x | 1.38x | 1.27x | 1.55x | 1.36x | 0.80x | 0.84x | 0.80x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | -2.50% | 8.64% | -18.90% | 10.92% | -19.49% | -18.64% | -72.46% | -21.15% | -20.33% | -22.00% |
| Operating Profit Growth % | 7.25% | 67.30% | -45.59% | -9.62% | -90.88% | 125.44% | -115.72% | -2736.95% | 87.69% | 62.25% |
| Net Profit Growth % | 16.13% | 155.73% | -64.44% | -24.61% | -290.21% | 34.12% | 5.89% | -385.64% | 86.17% | 29.67% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 86.17% | 29.67% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -17.10x | -45.38x |
Mar 2016
- EPS (₹)
- 51.64
- Book Value (₹)
- 321.01
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 17.90
- Operating Margin %
- 18.32%
- Net Margin %
- 6.22%
- ROE %
- 16.50%
- ROCE %
- 11.93%
- 4.25%
- Debtor Days
- 89
- Inventory Days
- 125
- Payable Days
- 104
- 110
- Debt to Equity (x)
- 1.63x
- Interest Coverage (x)
- 2.17x
- 1.26x
- Revenue Growth %
- -2.50%
- Operating Profit Growth %
- 7.25%
- Net Profit Growth %
- 16.13%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 26.41
- Book Value (₹)
- 85.93
- Dividend per Share (₹)
- 0.40
- Cash EPS (₹)
- 33.60
- Operating Margin %
- 28.22%
- Net Margin %
- 14.64%
- ROE %
- 35.18%
- ROCE %
- 21.86%
- 10.44%
- Debtor Days
- 66
- Inventory Days
- 122
- Payable Days
- 118
- 70
- Debt to Equity (x)
- 1.45x
- Interest Coverage (x)
- 5.23x
- 1.34x
- Revenue Growth %
- 8.64%
- Operating Profit Growth %
- 67.30%
- Net Profit Growth %
- 155.73%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 9.44
- Book Value (₹)
- 104.60
- Dividend per Share (₹)
- 0.40
- Cash EPS (₹)
- 16.06
- Operating Margin %
- 18.93%
- Net Margin %
- 6.42%
- ROE %
- 9.76%
- ROCE %
- 9.04%
- 3.43%
- Debtor Days
- 73
- Inventory Days
- 158
- Payable Days
- 145
- 86
- Debt to Equity (x)
- 0.69x
- Interest Coverage (x)
- 2.04x
- 1.62x
- Revenue Growth %
- -18.90%
- Operating Profit Growth %
- -45.59%
- Net Profit Growth %
- -64.44%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 6.95
- Book Value (₹)
- 70.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 15.04
- Operating Margin %
- 15.43%
- Net Margin %
- 4.36%
- ROE %
- 7.95%
- ROCE %
- 7.03%
- 2.44%
- Debtor Days
- 88
- Inventory Days
- 153
- Payable Days
- 175
- 66
- Debt to Equity (x)
- 1.05x
- Interest Coverage (x)
- 1.94x
- 1.38x
- Revenue Growth %
- 10.92%
- Operating Profit Growth %
- -9.62%
- Net Profit Growth %
- -24.61%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- -13.16
- Book Value (₹)
- 56.85
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.09
- Operating Margin %
- 1.75%
- Net Margin %
- -10.31%
- ROE %
- -20.75%
- ROCE %
- -2.69%
- -4.83%
- Debtor Days
- 104
- Inventory Days
- 184
- Payable Days
- 206
- 82
- Debt to Equity (x)
- 1.18x
- Interest Coverage (x)
- -0.79x
- 1.27x
- Revenue Growth %
- -19.49%
- Operating Profit Growth %
- -90.88%
- Net Profit Growth %
- -290.21%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -8.67
- Book Value (₹)
- 47.47
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.98
- Operating Margin %
- 4.84%
- Net Margin %
- -8.34%
- ROE %
- -16.62%
- ROCE %
- -1.12%
- -4.13%
- Debtor Days
- 76
- Inventory Days
- 160
- Payable Days
- 134
- 102
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- -0.25x
- 1.55x
- Revenue Growth %
- -18.64%
- Operating Profit Growth %
- 125.44%
- Net Profit Growth %
- 34.12%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -8.16
- Book Value (₹)
- 39.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.95
- Operating Margin %
- -2.76%
- Net Margin %
- -28.51%
- ROE %
- -18.80%
- ROCE %
- -3.54%
- -5.29%
- Debtor Days
- 150
- Inventory Days
- 382
- Payable Days
- 91
- 441
- Debt to Equity (x)
- 1.10x
- Interest Coverage (x)
- -0.62x
- 1.36x
- Revenue Growth %
- -72.46%
- Operating Profit Growth %
- -115.72%
- Net Profit Growth %
- 5.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -39.62
- Book Value (₹)
- 0.17
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -26.55
- Operating Margin %
- -99.42%
- Net Margin %
- -175.59%
- ROE %
- -200.51%
- ROCE %
- -55.28%
- -29.06%
- Debtor Days
- 158
- Inventory Days
- 313
- Payable Days
- 65
- 405
- Debt to Equity (x)
- 266.22x
- Interest Coverage (x)
- -8.13x
- 0.80x
- Revenue Growth %
- -21.15%
- Operating Profit Growth %
- -2736.95%
- Net Profit Growth %
- -385.64%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -5.48
- Book Value (₹)
- -5.24
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -3.08
- Operating Margin %
- -22.05%
- Net Margin %
- -30.49%
- ROE %
- 0.00%
- ROCE %
- -12.01%
- -4.67%
- Debtor Days
- 192
- Inventory Days
- 176
- Payable Days
- 254
- 115
- Debt to Equity (x)
- -8.67x
- Interest Coverage (x)
- -14.36x
- 0.84x
- Revenue Growth %
- -20.33%
- Operating Profit Growth %
- 87.69%
- Net Profit Growth %
- 86.17%
- 86.17%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -17.10x
Mar 2025
- EPS (₹)
- -3.85
- Book Value (₹)
- -8.82
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -1.42
- Operating Margin %
- -11.19%
- Net Margin %
- -27.49%
- ROE %
- 0.00%
- ROCE %
- -9.07%
- -3.42%
- Debtor Days
- 246
- Inventory Days
- 193
- Payable Days
- 255
- 185
- Debt to Equity (x)
- -5.14x
- Interest Coverage (x)
- -9.69x
- 0.80x
- Revenue Growth %
- -22.00%
- Operating Profit Growth %
- 62.25%
- Net Profit Growth %
- 29.67%
- 29.67%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -45.38x
Documents
Announcements
- Corporate Insolvency Resolution Process
2026-08-17 - Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
- Clarification - Financial Results
2026-07-31 - The Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
Annual Reports
Credit Ratings
Nothing filed yet.